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Chlamydia trachomatis and Neisseria gonorrhoeae are well-established causes of PID and routine screening for these pathogens has been implemented worldwide with the goal of interrupting progression or reducing transmission to prevent long term reproductive morbidity. However, both microbes remain a significant public health burden. Management of sexually transmitted infections (STI) may be improved by identifying biomarkers that can be used to predict pathology or can be used for vaccine development. 2 However, a factor complicating control efforts is the range of clinical outcomes observed after bacterial STIs. 2 The reasons for this variability are not clear because the mechanisms underlying the immunopathogenesis of C. trachomatis and N.
gonorrhoeae have yet to be elucidated fully.
Studies focused on identifying bacterial, clinical, and environmental factors associated with late complications after C. trachomatis infection have failed to identify prognostic or diagnostic markers associated with reproductive morbidity. 3 We have shown that N. gonorrhoeae coinfection increases the risk for ascending as well as incident chlamydial infection, 4 indicating that coinfection likely contributes to risk for upper genital tract disease. Host genetics also influences disease progression among infected women by modulating immune responses. 5, 6 A study of 64 Gambian twin pairs estimated that host genetics accounts for approximately 39% of variation in C. trachomatis outcome. 6 We previously reported that single nucleotide polymorphisms (SNPs) in Toll-like receptor (TLR) 1 and 4 genes, innate inflammatory receptors, are associated with C. trachomatis infection, upper genital tract infection with C. trachomatis and/or N. gonorrhoeae and reduced pregnancy rates among African American women with PID. 7 This suggests that some women may be predisposed to disproportionate and potentially damaging inflammatory responses after innate immune recognition of STIs.
Variants identified via candidate gene studies explain a small fraction of individual variation for long-term morbidity risk and focus only on known pathophysiological pathways. High throughput technologies, such as next generation sequencing, 8 support broader, unbiased detection of genetic variation. Compared with whole-genome sequencing, whole-exome sequencing (WES) is a more cost-effective approach to increase our understanding of many complex diseases. 9 Whole-exome sequencings may be particularly useful to reveal novel and rare coding variants across the genome to support inferences regarding biologically relevant pathways. Whole-exome sequencing is yet to be applied to the identification of host genetic factors that influence progression of upper genital tract infection to infertility. However, the ability of WES to identify a single-variant association with a disease is limited by the need for large samples sizes and the challenge of finding adequately characterized patient samples. 10 The objective of this discovery phase study was to use novel methods, such as variant pooling tests and pathway analyses, to obtain useful biological information from WES. Pathway-based tests are more powerful than single-variant association tests and may be more appropriate given that a complex disease, such as PID, is unlikely to have a single causal variant but could be modulated by multiple causal genes within a biological pathway. 10 We anticipate that these analyses will support development of mechanistic hypotheses related to the pathophysiology of infertility following PID in women with C. trachomatis infection with or without N. gonorrhoeae coinfection. We expect that biologically relevant pathways identified by this study will be the basis of a larger follow-up study using targeted sequencing to improve understanding of STI-driven infertility.
MATERIALS AND METHODS

Patient Population
Study participants were selected from a large cohort of individuals who participated in the PID Evaluation and Clinical Health (PEACH) study, a randomized clinical trial that compared inpatient and outpatient treatment for preventing long-term complications among 831 women with clinically suspected PID. 11 Briefly, between March 1996 and February 1999 women aged 14 to 37 years were recruited from 7 primary and 6 secondary sites throughout the United States. Eligible women had a history of pelvic discomfort for less than 30 days, findings of pelvic organ tenderness (uterine or adnexal) on bimanual examination, and leukorrhea and/or mucopurulent cervicitis and/or untreated but documented gonococcal or chlamydial cervicitis. Women with suspected PID, and who provided informed consent, were eligible to participate in the treatment trial, approved by the University of Pittsburgh Institutional Review Board.
The PEACH study collected blood from 692 of the 831 women enrolled for measurement of erythrocyte sedimentation rate and any residual sample was frozen and archived for subsequent studies. Our previous genetic study focused on 290 PEACH participants with DNA available for analysis. 7 Among these women, 70% were African American, 18% were white, 8% were Hispanic, and 4% were of other races, which reflected the distribution of the overall study. A total of 94 of 205 non-Hispanic African American women had C. trachomatis. This investigation included 43 of these women who had stored DNA remaining (15 [35%] of 43 were coinfected with N. gonorrhoeae). This group was selected because narrowing our focus to a single racial/ethnic group reduced population stratification, which can lead to erroneous results. In addition, African American women have the highest risk for chlamydia and PID. The Texas A&M University Institutional Review Board approved this study.
Data Collection
Women enrolled in PEACH were followed up for a median of 84 months, and extensive data on STIs and reproductive morbidities were obtained. An extensive interview, administered at enrollment, collected demographic and clinical information regarding reason for visit, pain history, history of PID/STIs, sexual and contraceptive practices, reproductive decisions, douching, pregnancies, medical and gynecological history, and lifestyle habits. A gynecological examination was also performed. Vaginal smears were gram stained for diagnosis of bacterial vaginosis by Nugent criteria. Endometrial biopsy specimens were obtained for histology. Endometritis was based on a modification of the criteria proposed by Kiviat et al 12 and defined as the presence of at least 5 neutrophils in the endometrial surface epithelium in the absence of menstrual endometrium and/or at least 2 plasma cells in the endometrial stroma. Cervical and endometrial swabs were also stored and later used to test for Mycoplasma genitalium.
Reproductive outcomes monitored during follow-up for the PEACH study included pregnancy, infertility, live birth, recurrent PID, and chronic pelvic pain. In PEACH, infertility was assessed among sexually active women reporting no birth control or methods considered being unreliable, including withdrawal, rhythm method, vasectomy, or using the following methods rarely or occasionally-diaphragm, condoms, spermicidal foam/cream/jelly/suppositories, or cervical cap. Women were determined to be infertile if they did not conceive (positive urine or blood test, or doctor's diagnosis of pregnancy) during follow-up (≥12 months).
WES and Bioinformatics
An estimated 2 μg of stored DNA was shipped to Genomics and Bioinformatics Services, Texas A&M AgriLife for WES. Libraries were constructed using TruSeq Exome Enrichment kits (Illumina) and sequenced on the Illumina HiSeq 2500 platform as paired end 100 bp reads. Quality control for the raw reads was archived using Fastq-mcf Toolkit (REF) to filter, trim, and correct reads. Reads were aligned by comparison with the standard reference genome GRch38. Polymerase chain reaction duplications were removed and reads were realigned around potential indel regions using standard GATK version 2.6.5 procedures. 13 Variants were filtered for quality control if there was strand bias (Fisher score >60), low coverage (<5 reads), low-quality score (<50), or read depth (<8Â).
Statistical Analyses
Logistic regression with Firth's penalized likelihood approach was used to examine associations between baseline variables and infertility to identify potential covariates. No significant associations between potential covariates and infertility were detected so unadjusted models are presented. Principal component analysis was conducted but did not identify any significant population stratification (PLINK V 9).
Sequencing Kernel Association Test
To examine associations between the aggregate effects of variants on a single gene and infertility, we used the sequencing kernel association test (SKAT). 9 This is a variance-component test within a random effects model that evaluates the distribution of genetic effects of multiple variants on a single gene (ie, examining cumulative variant gene-disease associations) and can account for bidirectionality of variant effect sizes within a gene. 9 Thus, SKAT calculates P values where the outcome is infertility and the genetic independent variable is not a single variant but rather an aggregate of variants from a single gene. We ranked genes according to P value and selected a set of "focus genes" with P values <0.01 (n = 150 genes) for subsequent pathway analysis. All analyses were conducted with R V3.2.2.
Ingenuity Pathway Analysis
We used Ingenuity Pathway Analysis (IPA) (Redwood City, CA), 14 to understand biological relationships, if present, between the 150 focus genes identified via WES. Pathway analyses have greater power to identify biologically relevant genes compared with single variant or gene-disease association tests. 10 Canonical biochemical or signaling pathways are based on the data accumulated in the IPA knowledge base. Significant associations between a gene set and a canonical pathway are determined using the ratio of the number of focus genes mapping to a canonical pathway divided by the total number of genes from the IPA knowledge base that map to that pathway. Ingenuity Pathway Analysis ranks focus genes by significance where the P value (Fisher exact test) determines the probability that a set of focus genes (gene sets) is enriched for a specific canonical pathway more than would be expected by chance alone.
RESULTS
Among the subset of PEACH participants assessed via WES (n = 43), a total of 13 women were classified as infertile at follow-up, while the remainder (n = 30) were fertile. Compared with fertile women, infertile women were more likely to be older than 35 years (23.1% vs 10.0%), have 12+ years of education (38.6% vs 16.7%), report a previous history of chlamydia (50.0% vs. 33.3%), and to have N. gonorrhoeae co-infection (66.7% vs. 37.5%), although none of these differences reached statistical significance. History of PID, history of gonorrhea, histologic endometritis, M. genitalium coinfection, BV, and smoking status did not significantly differ between groups (Table 1) .
Sequencing Kernel Association Test
We identified a total of 324,913 SNPs by WES. After removing missing data and unspecified gene locations, a total of 85,315 SNPs linked to 17,873 genes were included in the SKAT test. Variants associated with infertility were found for 668 genes (P < 0.05), with 150 focus genes being identified with P values <0.01. Table 2 shows a select subset of these genes with P values <0.0005 (determined by SKAT: bone morphogenetic protein 3 [BMP3], POLR2J3, C1RL, NME4, POFUT2, TMEM70, and ASS1). These genes have functions related to cellular growth (BMP3); RNA polymerase activity (POLRJ2); complement activation, immune system regulation and response (C1RL), adenosine triphosphate (ATP) binding or transport (NME4, TREM70); metabolic responses (POFUT2); and cellular response to IFN-γ (ASS1). However, none of the focus genes would remain significant at the Bonferroni threshold of 2.8E-06. Figures 1-3 show the top 3 canonical pathways enriched with respect to focus genes. These canonical pathways included IL-1 signaling pathways (Fig. 1) , P2Y purinergic receptor (Fig. 2) , and BMP signaling (Fig. 3) . Genes enriched in these canonical pathways have several relevant biological functions including innate immune signaling, G protein-coupled receptor signaling, protein kinase A activity, platelet aggregation, and cell growth and differentiation.
IPA Canonical Pathways
DISCUSSION
We used WES to examine the aggregated effects of multiple variants on a single gene to identify potential associations with infertility after PID. Focus genes displayed in Table 2 represented associations with infertility that had the lowest corresponding P values. These genes impact BMP signaling that orchestrates tissue architecture throughout the body, immune function and complement (C1RL, ASS1), metabolism (POFUT2), RNA polymerase (POLR2J3), and ATP binding or synthesis (NME4, TMEM70). The relationship between some of these biological functions and STIs is described below. It is less clear how POFUT2 or POLR2J3 function would impact infertility. POFUT2 is linked to cancer, 15 and there is a growing appreciation that changes in immune cell function, particularly T cell proliferation and T cell effector signaling pathways, are dependent on metabolic state. 16 There is no information on POLR2J3 in the literature. However, none of these focus genes have been directly linked to STIs, and associations were not significant after correction for multiple comparisons.
The top 150 focus genes after SKAT testing were included in Ingenuity Pathway Analyses to identify biologically relevant canonical pathways common among the focus genes. Several focus genes (N = 4) were enriched in the canonical IL-1 signaling pathway (Fig. 1) . IL-1 is involved in tissue destruction in human fallopian tubes after C. trachomatis infection. 17 Specifically, IL-1 receptor antagonist (IL-1RA) eliminates tissue damage induced by C. trachomatis in human fallopian tube organ culture. The mouse model of chlamydial genital tract disease reveals IL-1 is a key mediator of oviduct damage. Thus, variants in this pathway may exacerbate tissue damage after C. trachomatis infection. 18 One focus gene in this pathway, IL-1 receptor associated kinase 2 (IRAK2) is involved in TLR function and is upregulated after C. trachomatis infection. 19 Indeed, we have previously linked the TLR1 gene and TLR4 gene to C. trachomatis and upper genital tract pathology. 6 Other focus genes in this pathway have not been directly linked to STIs. However, TGF-β activated kinase 1/MAP3K7 binding protein 1 (TAB1) dependent activation of MAPK is involved in T-cell senescence which could alter proliferation and adaptive immunity. 20 Our results are consistent with the hypothesis that altered function in immune pathways may be involved in C. trachomatis pathogenesis.
Some focus genes within the IL-1 signaling pathway (adenylate cyclase [ADCYL] and protein kinase cAMP-activated catalytic subunit beta [PRKCH]) were also enriched in the P2Y Purinergic Receptor Signaling pathway (Fig. 2) . However, there is little information on the possible role of purinergic receptor signaling in STIs. The purinergic receptor P2X7R has been shown to inhibit C. trachomatis infection in epithelial cells via ATP mediation. 21 Purinergic receptors have been implicated in immune cell trafficking 22 and in the development of fibrosis through the binding of ATP and ADP. 23 These receptors may also contribute to T-cell activation. 24 Lastly, focus genes were enriched in the BMP canonical pathway (Fig. 3 ) that impacts TGF-β signaling, cell growth, and apoptosis. Gene variants in this pathway could alter the immune response to N. gonorrhoeae as well as C. trachomatis. Mouse models have shown that N. gonorrhoeae induces TGF-β to suppress the host immune response and blockade of TGF-β improves host defense against this pathogen. 25 Genes that regulate apoptosis can be manipulated by pathogens to increase the probability of Figure 2 . Displays canonical P2Y Purinergic Receptor Signaling pathway identified through IPA. Genes highlighted in pink represent focus genes. ADCYL is involved in biological processes including activation of protein kinase A activity and G-protein coupled receptor signaling. ITGA2B is involved in cell adhesion, regulation of leukocyte migration and platelet aggregation. PLCD is involved in angiogenesis and is a regulator of cell proliferation. PRKACB is involved in activation of protein kinase A activity and G-protein coupled receptor signaling. PRKCH is involved in cell differentiation and proliferation, apoptosis, and NFκB activity. PLCD, (PLC) phospholipase C delta 1; ITGA2B, (GpIIB/IIA) integrin subunit alpha 2b); PRKCH, (PKC) protein kinase C eta).
replication and survival. Both N. gonorrhoeae and C. trachomatis have been shown to modulate apoptosis pathways to avoid host defense mechanisms. 26, 27 BMP genes and antagonist gremlin 1 (GREM1) are involved in inflammation and tissue damage. 28 Although there is no direct link to bacterial STIs, BMP3 is involved in hepatitis C virus-induced cirrhosis. 29 Thus, it is possible that variants involved in this pathway that affect cellular repair or growth may lead to tissue damage after persistent infection.
Our study used data with long-term follow-up that enabled us to examine infertility after clinically suspected PID. We did not have access to laparoscopic findings and relied on self-report to determine infertility. Thus, misclassification is possible. However, PEACH is one of only a few studies that have assessed reproductive morbidity after clinical PID. There is no widely accepted approach for the analysis of WES data or for the selection of candidate genes in the discovery phase. 8 The use of the SKAT test allowed us to capture regions that may have a high proportion of causal or noncausal variants with bidirectionality. However, given our sample size, this test was not powerful enough to detect significant associations after correction for multiple comparisons. Methods of correction for multiple comparisons for sequencing studies are not established and existing methods including Bonferroni and FDR are suggested to be suboptimal. 30 Thus, relying on strict multiple comparison correction in exome sequencing studies may lead to ruling out potentially important associations. Overall, pathway analyses are a more powerful approach to identify biologically relevant pathways that may be related to disease. 9 The limitation of these analyses is that correction for control of type I error is still not well developed. 9 This was the first study to use WES to identify novel biological pathways that may be associated with STI-related infertility. The IL-1 signaling pathway is of interest because variations in this pathway may enhance disease after infection. Pathways that impact tissue repair and growth (BMP pathway) may be involved in the formation of scarring or enhanced cellular damage after infection. Our study identified biologically relevant pathways that may serve as targets for a larger study using targeted sequencing. Other avenues of research should include examining some of the identified novel pathways of interest (ie, BMP signaling and Purinergic Receptor) in animal models. As STI's remain a major public health burden, the use of genomics in STI research may enhance our understanding of pathogenesis. This could lead to the identification of biomarkers for prediction of tissue damage and perhaps contribute toward vaccine development. Biomarkers of upper genital tract infection might also be useful for monitoring efficacy in vaccine trials.
